LMR Partners’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

LMR Partners’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364	Hold	75,731	–	–	﹤0.01%	1488
2026 Q1	$1.56K	Hold	75,731	–	–	﹤0.01%	1406
2025 Q4	$1.84K	Hold	75,731	–	–	﹤0.01%	1476
2025 Q3	$2.97K	Hold	75,731	–	–	﹤0.01%	1407
2025 Q2	$2.98K	Hold	75,731	–	–	﹤0.01%	1319
2025 Q1	$3.56K	Hold	75,731	–	–	﹤0.01%	1295
2024 Q4	$2.6K	Buy	+75,731	New	+$3.7K	﹤0.01%	1148
2024 Q3	–	Sell	-60,771	Closed	-$4.68K	–	1475
2024 Q2	$3.69K	Hold	60,771	–	–	﹤0.01%	1051
2024 Q1	$18.2K	Hold	60,771	–	–	﹤0.01%	1035
2023 Q4	$29.8K	Hold	60,771	–	–	﹤0.01%	820
2023 Q3	$10.3K	Hold	60,771	–	–	﹤0.01%	818
2023 Q2	$11.5K	Buy	+60,771	New	+$11.1K	﹤0.01%	762

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

LMR Partners's RCKTW Position: Q2 2026 in Review

LMR Partners held its Rocket Pharmaceuticals Warrant (RCKTW) position steady in Q2 2026 at 75,731 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

LMR Partners first reported a position in RCKTW in Q2 2023 and has held it in 12 quarters since. The position peaked at $29.8K in Q4 2023. 11 funds tracked by Wall St. Rank hold RCKTW as of Q2 2026.

LMR Partners held 75,731 shares of Rocket Pharmaceuticals Warrant worth $364 as of Q2 2026.
LMR Partners left its Rocket Pharmaceuticals Warrant share count unchanged in Q2 2026.
Rocket Pharmaceuticals Warrant made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1488 holding.
LMR Partners first reported a position in Rocket Pharmaceuticals Warrant in Q2 2023 and has held it in 12 quarters since.
LMR Partners's Rocket Pharmaceuticals Warrant position peaked at $29.8K in Q4 2023.
11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.